These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 16228142)

  • 21. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study.
    Lloyd-Jones DM
    Curr Cardiol Rep; 2001 May; 3(3):184-90. PubMed ID: 11305971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.
    He J; Ogden LG; Bazzano LA; Vupputuri S; Loria C; Whelton PK
    Arch Intern Med; 2001 Apr; 161(7):996-1002. PubMed ID: 11295963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study.
    Kupari M; Lindroos M; Iivanainen AM; Heikkilä J; Tilvis R
    J Intern Med; 1997 May; 241(5):387-94. PubMed ID: 9183306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological aspects of heart failure.
    Kannel WB
    Cardiol Clin; 1989 Feb; 7(1):1-9. PubMed ID: 2523239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal blood pressure pattern and risk of congestive heart failure.
    Ingelsson E; Björklund-Bodegård K; Lind L; Arnlöv J; Sundström J
    JAMA; 2006 Jun; 295(24):2859-66. PubMed ID: 16804152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults.
    Rich MW
    J Am Geriatr Soc; 1997 Aug; 45(8):968-74. PubMed ID: 9256850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profile for estimating risk of heart failure.
    Kannel WB; D'Agostino RB; Silbershatz H; Belanger AJ; Wilson PW; Levy D
    Arch Intern Med; 1999 Jun; 159(11):1197-204. PubMed ID: 10371227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.
    Redfield MM; Jacobsen SJ; Burnett JC; Mahoney DW; Bailey KR; Rodeheffer RJ
    JAMA; 2003 Jan; 289(2):194-202. PubMed ID: 12517230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification in hypertension: new insights from the Framingham Study.
    Kannel WB
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):3S-10S. PubMed ID: 10678282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
    Lloyd-Jones DM; Larson MG; Leip EP; Beiser A; D'Agostino RB; Kannel WB; Murabito JM; Vasan RS; Benjamin EJ; Levy D;
    Circulation; 2002 Dec; 106(24):3068-72. PubMed ID: 12473553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and prognosis of congestive heart failure in Saudi patients admitted with acute coronary syndrome (from SPACE registry).
    Albackr HB; Alhabib KF; Ullah A; Alfaleh H; Hersi A; Alshaer F; Alnemer K; Al Saif S; Taraben A; Kashour T
    Coron Artery Dis; 2013 Nov; 24(7):596-601. PubMed ID: 23928809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men.
    Arnlöv J; Ingelsson E; Risérus U; Andrén B; Lind L
    Eur Heart J; 2004 Dec; 25(24):2220-5. PubMed ID: 15589639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy as a risk factor: the Framingham experience.
    Kannel WB
    J Hypertens Suppl; 1991 Dec; 9(2):S3-8; discussion S8-9. PubMed ID: 1838765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.
    Kitzman DW; Gardin JM; Gottdiener JS; Arnold A; Boineau R; Aurigemma G; Marino EK; Lyles M; Cushman M; Enright PL;
    Am J Cardiol; 2001 Feb; 87(4):413-9. PubMed ID: 11179524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of sudden coronary death: population at risk.
    Kannel WB; Gagnon DR; Cupples LA
    Can J Cardiol; 1990 Dec; 6(10):439-44. PubMed ID: 2148709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global epidemiology of heart failure.
    Young JB
    Med Clin North Am; 2004 Sep; 88(5):1135-43, ix. PubMed ID: 15331310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.